Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases

Hormone Research

Volumn 70, Issue 3, 2008, Pages 155-164

  Bossowski, A ^a   Czarnocka, B ^b   Bardadin, K ^b   Urban, M ^a   Niedziela, M ^c   Dadan, J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Apoptosis; Bcl 2 family; Graves' disease

Indexed keywords

ANTITHYROID AGENT; PROPRANOLOL; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; THIAMAZOLE; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GRAVES DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTHYROIDISM; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NODULAR GOITER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCHOOL CHILD; THYROID CELL; THYROIDECTOMY; TOXIC GOITER; WESTERN BLOTTING;

EID: 47949127678     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000145017     Document Type: Article

References (22)

1. Kawakami A, Eguchi K: Involvement of apoptotic cell death in autoimmune diseases. Med Electron Microsc 2002;35:1-8.
2. Bossowski A, Moniuszko A, Boużyk J, Urban M: Role of apoptosis in autoimmune thyroid diseases. Endocrinol Diabetol Metabol Dis Dev Age 2006;12:216-220.
3. Hengartner MO: The biochemistry of apoptosis. Nature 2000;407:770-776.
4. Salvesen GS, Dixit VM: Caspases: intracellular signaling by proteolysis. Cell 1997;91:443-446.
5. Kroemer G, Zamzami N, Susin SA: Mitochondria control of apoptosis. Immunol Today 1997;18:44-51.
6. Green DR, Reed JC: Mitochondria and apoptosis. Science 1998;281:1309-1312.
7. Kroemer G: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997;3:614-620.
8. Palazzo FF, Hammond LJ, Goode AW, Mirakian R: Death of the autoimmune thyrocyte: is it pushed or does it jump? Thyroid 2000;10:561-572.
9. Hammond LJ, Lowdell MW, Cerrano PG, Goode AW, Bottazzo GF, Mirakian R: Analysis of apoptosis in relation to tissue destruction associated with Hashimoto's autoimmune thyroiditis. J Pathol 1997;182:138-144.
10. Hiromatsu Y, Kaku H, Mukai T: Immunohistochemical analysis of Bcl-2, Bax and Bak expression in thyroid glands from patients with Graves' disease. Endocr J 2004;51:399-405.
11. Adams J.M, Cory S: Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 2001;26:61-66.
12. Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, Erdjument-Bromage H, Tempst P, Korsmeyer SJ: Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 1999;274:1156-1163.
13. Hu Y, Benedict MA, Wu D, Inohara N, Nunez G: Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci USA 1998;95:4386-4391.
14. Pan G, O'Rourke K, Dixit VM:Caspase-9, Bcl-XL and Apaf-1 form a ternary complex. J Biol Chem 1998;273:5841-5845.
15. Reed JC: Double identity for protein of the Bcl-2 family. Nature 1997;387:773-776.
16. Roura-Mir C, Catalfamo M, Sospedra M, Alcalde L, Pujol-Borrell R, Jaraquemada D: Single-cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's thyroiditis and Graves' disease. Eur J Immunol 1997;27:3290-3302.
17. Vella V, Mineo R, Frasca F, Mazzon E, Pandini G, Vigneri R, Belfiore A: Interleukin-4 stimulates thyroid cancer cell survival: implications in patients with thyroid cancer and concomitant Graves' disease. J Clin Endocrinol Metab 2004;89:2880-2889.
18. De la Vega JR, Vilaplana JC, Biro A, Hammand L, Bottazzo GF, Mirakian R: IL-10 expression in thyroid glands: protective or harmful role against thyroid autoimmunity? Clin Exp Immunol 1998;113:126-135.
19. Riou C, Tonoli H, Bernier-Valentin F, Rabilloud R, Fonlupa P, Rousset B: Susceptibility of differentiated thyrocytes in primary culture to undergo apoptosis after exposure to hydrogen peroxide: relation with the level of expression of apoptosis regulatory proteins, Bcl-2 and Bax. Endocrinology 1999;140:1990-1997.
20. Andrikoula M, Vartholomatos G, Tsangaris GT, Bafa M, Tzortzatou- Stathopoulou F, Tsatsoulis A: Fas and Bcl-2 protein expression in thyrocytes of patients with nodular goiter. Eur J Endocrinol 2001;145:403-407.
21. Labat-Moleur F, Chabre O, Guillermet C, Chaffanjon P, Blumet-Rondeu F, Bauchet A, Franc B, Brambilla E, Bachelot I, Dumont JE, Negoescu A: Graves-Basedow disease goiter: a model of Bax-Bcl-2 regulated apoptosis. Thyroid 1999;9:483-492.
22. Yehuda-Shnaidman E, Kalderon B, Bar-Tana J:Modulation of mitochondrial transition pore components by thyroid hormone. Endocrinology 2005;146:2462-2472.